Cargando…
Emergence of Nosocomial Pneumonia Caused by Colistin-Resistant Escherichia coli in Patients Admitted to Chest Intensive Care Unit
(1) Background: Colistin is a last-resort antibiotic used in treating multidrug-resistant Gram-negative infections. The growing emergence of colistin resistance in Escherichia coli (E. coli) represents a serious health threat, particularly to intensive care unit (ICU) patients. (2) Methods: In this...
Autores principales: | El-Mokhtar, Mohamed A., Daef, Enas, Mohamed Hussein, Aliae A. R., Hashem, Maiada K., Hassan, Hebatallah M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996192/ https://www.ncbi.nlm.nih.gov/pubmed/33668302 http://dx.doi.org/10.3390/antibiotics10030226 |
Ejemplares similares
-
Prognostic biomarkers in COVID-19 infection: value of anemia, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and D-dimer
por: Hashem, Maiada K., et al.
Publicado: (2021) -
Impact of comorbidities on COVID-19 outcome
por: khedr, Eman M, et al.
Publicado: (2020) -
Comorbidities and outcomes among patients hospitalized with COVID-19 in Upper Egypt
por: Khedr, Eman M., et al.
Publicado: (2022) -
Sero-prevalence of anti-SARS-CoV-2 antibodies among healthcare workers: A multicenter study from Egypt
por: El-Sokkary, Rehab H., et al.
Publicado: (2021) -
Prevalence and early outcome of bronchiectasis as an atypical presentation in COVID-19 patients
por: Hussein, Aliae A. R. Mohamed, et al.
Publicado: (2022)